ANTONYOVÁ, Veronika, Zdeněk KEJÍK, Tereza BROGYANYI, Robert KAPLÁNEK, Kateřina VESELÁ, Nikita ABRAMENKO, Tomáš OCELKA, Michal MASAŘÍK, Adam MATKOWSKI, Jakub GBUREK, Renata ABEL, Andrean GOEDE, Robert PREISSNER, Petr NOVOTNÝ and Milan JAKUBEK. Non-psychotropic cannabinoids as inhibitors of TET1 protein. Bioorganic Chemistry. San Dieo: ACADEMIC PRESS INC ELSEVIER SCIENCE, 2022, vol. 124, July 2022, p. 1-8. ISSN 0045-2068. Available from: https://dx.doi.org/10.1016/j.bioorg.2022.105793.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Non-psychotropic cannabinoids as inhibitors of TET1 protein
Authors ANTONYOVÁ, Veronika (203 Czech Republic), Zdeněk KEJÍK (203 Czech Republic), Tereza BROGYANYI (203 Czech Republic), Robert KAPLÁNEK (203 Czech Republic), Kateřina VESELÁ (203 Czech Republic), Nikita ABRAMENKO (203 Czech Republic), Tomáš OCELKA (203 Czech Republic), Michal MASAŘÍK (203 Czech Republic, belonging to the institution), Adam MATKOWSKI (616 Poland), Jakub GBUREK (616 Poland), Renata ABEL (616 Poland), Andrean GOEDE (276 Germany), Robert PREISSNER (276 Germany), Petr NOVOTNÝ (203 Czech Republic) and Milan JAKUBEK (203 Czech Republic, guarantor).
Edition Bioorganic Chemistry, San Dieo, ACADEMIC PRESS INC ELSEVIER SCIENCE, 2022, 0045-2068.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30105 Physiology
Country of publisher Slovenia
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 5.100
RIV identification code RIV/00216224:14110/22:00125768
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1016/j.bioorg.2022.105793
UT WoS 000819757600001
Keywords in English Cannabinoids; TET1 protein; Iron chelation; DNA methylation; Epigenetic
Tags 14110515, 14110518, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 19/7/2022 10:51.
Abstract
Non-psychotropic cannabinoids (e.g., cannabidiol, cannabinol and cannabigerol) are contained in numerous alimentary and medicinal products. Therefore, predicting and studying their possible side effects, such as changes in DNA methylation, is an important task for assessing the safety of these products. Interference with TET enzymes by chelating ferrous ions can contribute to the altered methylation pattern. All tested cannabinoids displayed a strong affinity for Fe(II) ions. Cannabidiol and cannabinol exhibited potent inhibitory activities (IC50 = 4.8 and 6.27 μM, respectively) towards the TET1 protein, whereas cannabigerol had no effect on the enzyme activity. An in silico molecular docking study revealed marked binding potential within the catalytic cavity for CBD/CBN, but some affinity was also found for CBG, thus the total lack of activity remains unexplained. These results imply that cannabinoids could affect the activity of the TET1 protein not only due to their affinity for Fe(II) but also due to other types of interactions (e.g., hydrophobic interactions and hydrogen bonding).
Links
LM2018133, research and development projectName: Český národní uzel Evropské infrastruktury pro translační medicínu (Acronym: EATRIS-ERIC-CZ)
Investor: Ministry of Education, Youth and Sports of the CR
NU21-08-00407, research and development projectName: Funkční nanoroboti pro navigovanou kombinovanou nádorovou terapii
Investor: Ministry of Health of the CR, Subprogram 1 - standard
TN01000013, research and development projectName: Personalizovaná medicína - diagnostika a terapie
Investor: Technology Agency of the Czech Republic, Personalized Medicine – Diagnostics and Therapy
PrintDisplayed: 13/7/2024 16:48